Dr. Gabriele Wanninger and Dr. Silke Litzinger have just returned from their visit to BrightGene Bio-Medical Technology Co., Ltd in China. They spent four days reviewing the quality assurance measures for the construction of a new, state-of-the-art factory. This factory will produce sterile pharmaceuticals for the EU and US markets.

As quality assurance experts, Dr. Gabriele Wanninger and Dr. Silke Litzinger play a crucial role in providing advice on regulatory compliance ahead of inspections by authorities from the EU.